A new high-throughput platform for discovering potential ALS drugs
News
HSCI researchers use patient-derived motor neurons to screen for clinically relevant targets Harvard Stem Cell Institute (HSCI) researchers led by Clifford Woolf, M.D., Ph.D., have developed a high-throughput platform for discovering drug targets to treat...